Samjin Pharmaceutical Co.,Ltd. (South Korea)

Samjin Pharmaceuticals Co., Ltd. is a pharmaceutical company based in Seoul, South Korea. It was founded in 1968 and currently employs between 501 and 1,000 people. The company operates in the manufacturing and industrials, healthcare, and pharmaceutical manufacturing industries. Samjin Pharmaceuticals specializes in the research and development of pharmaceutical products, with a focus on specialized medicines for the treatment of chronic diseases in the aging society. They have developed expertise in areas such as anti-blood clot and high blood lipid therapies, circulatory drugs, brain neurosystems drugs, and digestive systems drugs. Samjin Pharmaceuticals has a strong commitment to innovation and collaboration, working with international research institutions and strategic partners to accelerate the development of new drugs. Their customers include both general medicine and specialized medicine clients in various clinical fields. Samjin Pharmaceuticals aims to contribute to the global drug market and improve human health through the development of novel medications. They have made significant advancements in pharmaceutical research and development, particularly in the field of global new drug development. Samjin Pharmaceuticals has established a strategic alliance with ImQuest BioSciences in the USA and has secured research grants and funding from the NIH for the development of medications for the prevention and treatment of AIDS. With their expertise, state-of-the-art technology, and wide range of trusted products, Samjin Pharmaceuticals has gained a competitive advantage in the global pharmaceutical market. They continue to pursue innovative solutions for addressing intractable terminal diseases such as AIDS and cancer.